Robert F. Friel

Robert F. Friel is a declared insider at 3 companies (senior executive); the most frequent names are Xylem Inc., West Pharmaceutical Services Inc and Revvity, Inc. In total, 13 filings cover trades dated from 5 February 2016 to 14 May 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 15 May 2026 with a share grant (€249k) in Xylem Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.